{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:31:09Z","timestamp":1767839469064,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P01 CA225618"],"award-info":[{"award-number":["P01 CA225618"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA06973"],"award-info":[{"award-number":["P30 CA06973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation and Cellular Therapy"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.jtct.2023.10.011","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T22:20:33Z","timestamp":1697062833000},"page":"208.e1-208.e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Allogeneic Hematopoietic Cell Transplantation with Non-Myeloablative Conditioning and Post-Transplant Cyclophosphamide Prophylaxis in Patients with Reduced Systolic Function"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5297-6887","authenticated-orcid":false,"given":"Frederick Ian","family":"LeMaistre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua-Ling","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ravi","family":"Varadhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tala","family":"Al-Talib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0855-9653","authenticated-orcid":false,"given":"Alexander","family":"Ambinder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtct.2023.10.011_bib0001","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrc2804","article-title":"Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer","volume":"10","author":"Jenq","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.jtct.2023.10.011_bib0002","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.011_bib0003","series-title":"SEER Cancer Statistics Review, 1975-2018","year":"2021"},{"key":"10.1016\/j.jtct.2023.10.011_bib0004","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1182\/blood-2017-03-772368","article-title":"Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States","volume":"130","author":"Muffly","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.011_bib0005","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1056\/NEJMoa2215943","article-title":"Post-transplantation cyclophosphamide-based graft-versus-host disease prophylaxis","volume":"388","author":"Bola\u00f1os-Meade","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jtct.2023.10.011_bib0006","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.011_bib0007","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.1992.10.6.995","article-title":"Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response","volume":"10","author":"Ayash LJ","year":"1992","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.011_bib0008","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.bmt.1703133","article-title":"Serious cardiac complications during bone marrow transplantation at the University of Minnesota, 1977\u20131997","volume":"28","author":"Murdych","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.011_bib0009","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1200\/JCO.1994.12.5.998","article-title":"Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant","volume":"12","author":"Hertenstein","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jtct.2023.10.011_bib0010","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jaccao.2021.02.011","article-title":"Early cardiac toxicity associated with post-transplant cyclophosphamide in allogeneic stem cell transplantation","volume":"3","author":"Dul\u00e9ry","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.jtct.2023.10.011_bib0011","doi-asserted-by":"crossref","first-page":"5599","DOI":"10.1182\/bloodadvances.2021004846","article-title":"Cardiac toxicity after matched allogeneic hematopoietic cell transplant in the posttransplant cyclophosphamide era","volume":"5","author":"Yeh","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtct.2023.10.011_bib0012","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1002\/cncr.30534","article-title":"Cardiomyopathy in patients after posttransplant cyclophosphamide-based hematopoietic cell transplantation","volume":"123","author":"Lin","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.jtct.2023.10.011_bib0013","series-title":"Common terminology criteria for adverse events, version 5.0","year":"2017"},{"key":"10.1016\/j.jtct.2023.10.011_bib0014","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1016\/j.jtct.2023.10.011_bib0015","article-title":"Cardiovascular diseases in patients after hematopoietic stem cell transplantation: systematic review and meta-analysis","volume":"71","author":"Alizadehasl","year":"2023","journal-title":"Curr Res Transl Med"},{"key":"10.1016\/j.jtct.2023.10.011_bib0016","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.bbmt.2009.06.001","article-title":"Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fraction","volume":"15","author":"Qazilbash","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.011_bib0017","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/bmt.2009.97","article-title":"Cardiac complications in patients undergoing a reduced-intensity conditioning hematopoietic stem cell transplantation","volume":"45","author":"Peres","year":"2010","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.011_bib0018","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/sj.bmt.1702783","article-title":"Severe cardiac toxicity in hematological stem cell transplantation: predictive value of reduced left ventricular ejection fraction","volume":"27","author":"Fujimaki","year":"2001","journal-title":"Bone Marrow Transplant"},{"issue":"suppl","key":"10.1016\/j.jtct.2023.10.011_bib0019","doi-asserted-by":"crossref","first-page":"S393","DOI":"10.1016\/j.bbmt.2019.12.323","article-title":"Cardiac toxicities after HLA-matched allogeneic hematopoietic cell transplantation (allo-HCT): post-transplant cyclophosphamide (PTCy) is not associated with higher incidence of cardiotoxicity","volume":"26","author":"Yeh J","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.011_bib0020","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbmt.2014.10.011","article-title":"Hematopoietic stem cell transplantation in patients with systolic dysfunction: can it be done?","volume":"21","author":"Hurley","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jtct.2023.10.011_bib0021","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror ML","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jtct.2023.10.011_bib0022","doi-asserted-by":"crossref","first-page":"665.e1","DOI":"10.1016\/j.jtct.2021.04.029","article-title":"Outcomes of fludarabine, melphalan and total body irradiation as a reduced-intensity conditioning regimen in matched donor allogeneic peripheral blood stem cell transplantation","volume":"27","author":"Modi","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.jtct.2023.10.011_bib0023","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1016\/j.bbmt.2017.06.014","article-title":"Hematopoietic cell transplantation-specific comorbidity index predicts morbidity and mortality in autologous stem cell transplantation","volume":"23","author":"Berro","year":"2017","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Transplantation and Cellular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723016135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666636723016135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T03:11:58Z","timestamp":1763003518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666636723016135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2666636723016135"],"URL":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.011","relation":{},"ISSN":["2666-6367"],"issn-type":[{"value":"2666-6367","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Allogeneic Hematopoietic Cell Transplantation with Non-Myeloablative Conditioning and Post-Transplant Cyclophosphamide Prophylaxis in Patients with Reduced Systolic Function","name":"articletitle","label":"Article Title"},{"value":"Transplantation and Cellular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtct.2023.10.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}